Impact of clinical target volume margin reduction in glioblastoma patients treated with concurrent chemoradiation.

Dario Di PerriDavid HofstedeDianne HartgerinkKarin TerhaagRuud HoubenAlida A PostmaAnn HoebenMonique AntenLinda AckermansInge CompterDaniëlle B P Eekers

Published in: Neuro-oncology practice (2023)

In GBM patients treated with chemoradiation, reducing the CTV margin from 20 to 15 mm appears to be safe and offers the potential for less treatment toxicity.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
oxidative stress
risk assessment
replacement therapy
smoking cessation